PhaseV

Scientist in a laboratory
PhaseV scores $50M for AI clinical trial platform
By Jessica Hagen | 03:10 pm | May 13, 2025
The company uses AI and ML to assist biopharma companies with clinical trials and will use the funds to expand its precision medicine and clinical development tools.